Bird Flu Spreading to More Humans and Animals: What You Need to Know

Bird flu — technically avian influenza — has been in the news repeatedly over the past several years, but the pattern of recent outbreaks has shifted in ways that make the current situation meaningfully different from prior episodes. The H5N1 strain that dominated headlines in the early 2000s affected mostly birds and a small number of people with direct poultry exposure. What has emerged more recently is a virus with a broader host range, a sustained presence in mammals, and a growing number of human infections — most linked to contact with infected animals, but enough cases to draw serious attention from public health agencies worldwide.

This article covers what bird flu is, why the current spread to mammals and humans matters, what the risk actually looks like for most people, and what the evidence says about preparation and prevention.

What Bird Flu Is — and Why H5N1 Gets the Most Attention

Avian influenza viruses are classified by two surface proteins: hemagglutinin (H) and neuraminidase (N). Dozens of subtypes exist, but H5N1 has received the most sustained concern because of its combination of characteristics: it spreads easily in birds, has demonstrated the ability to infect mammals including humans, and causes severe illness and high death rates in the humans who do get infected — historically around 60% mortality in confirmed cases, though this figure almost certainly reflects severe ascertainment bias, since mild cases likely go undetected and untested.

H5N1 has evolved into multiple clades (genetic lineages) over decades of circulating in wild birds and domestic poultry. The clade 2.3.4.4b variant, which drove the massive global outbreak in wild birds and poultry starting around 2021, proved capable of infecting a much wider range of mammal species than previous strains — including seals, sea lions, foxes, skunks, bears, mountain lions, and, critically, dairy cattle in the United States.

The H5N2 and H5N9 subtypes have also caused poultry outbreaks, and H7N9 circulated in China and caused human cases with high severity. But H5N1 clade 2.3.4.4b has dominated the recent expansion and accounts for the bulk of ongoing concern.

The Shift to Mammals — Why It Matters

For most of its history, H5N1 spread among birds and occasionally crossed into humans through direct contact with infected poultry. Sustained mammal-to-mammal transmission was not well established. Starting in 2022, that changed in visible ways. Mass die-offs of seals and sea lions in South America, Europe, and North America were linked to H5N1, suggesting marine mammals could transmit the virus among themselves. In 2024, H5N1 was detected in dairy cattle across multiple U.S. states — an unexpected host for influenza that had not been thought particularly susceptible — and the outbreak spread to hundreds of herds across dozens of states.

Why does mammal adaptation matter? Because pandemic influenza arises when a bird flu strain acquires the ability to transmit efficiently between humans. That requires the virus to adapt to replicate effectively in human respiratory cells, which are distributed differently and at different temperatures than bird respiratory cells. Each time H5N1 replicates in a mammal, it has opportunities to accumulate mutations toward that target. The dairy cattle outbreak, and the associated human infections in farm workers, represented the most sustained mammal-level circulation of H5N1 in a developed country with human population exposure that has occurred so far.

Human Cases: Who Gets Infected, and How

As of 2025 and into 2026, the majority of H5N1 human cases globally have been linked to direct contact with infected birds or animals. People who work on poultry farms, live poultry markets, or (more recently) dairy farms account for most cases. Casual contact — being near a bird in a park, encountering a dead bird while hiking — has not been a demonstrated transmission route for healthy adults.

The dairy cattle outbreak in the U.S. produced a substantial number of farm worker infections, most presenting with mild illness — predominantly conjunctivitis (eye infection) and mild respiratory symptoms rather than the severe pneumonia that characterized earlier H5N1 human cases. This may partly reflect a different exposure route (eye contact with contaminated material rather than inhalation of respiratory secretions), partly reflect the possibility that this viral variant causes milder disease in humans, and partly reflect better access to early antiviral treatment in the U.S. context.

One death in the U.S. linked to H5N1 was reported in 2025, in a person who had been hospitalized with severe respiratory illness after exposure to backyard birds and wild birds — the first fatal H5N1 case in the United States. This was a significant milestone that increased public health alertness, though it represented one severe case among a larger number of milder ones. Understanding the full spectrum of disease — from mild eye infection to fatal pneumonia — requires testing many more exposed individuals than public health systems have historically been able to screen.

Human-to-human transmission of H5N1 has not been demonstrated in a sustained way. Clusters of cases in households have occurred, but these appear to reflect shared exposure to the same infected animal rather than spread from one person to another. This distinction is the critical line that public health officials are monitoring most closely.

Which Animals Are Affected — The Expanding Host Range

The range of species confirmed infected with H5N1 clade 2.3.4.4b is broad and continues to grow. Wild birds remain the primary reservoir — the virus circulates in migratory waterfowl globally and periodically spills into domestic poultry. Beyond birds, confirmed mammal infections include wild carnivores (foxes, bears, skunks, raccoons, mink, otters), marine mammals (seals, sea lions, dolphins, porpoises), and most significantly for ongoing human exposure, domestic livestock including dairy cattle and a small number of goats.

Cats exposed to raw milk from infected cows have developed severe H5N1 illness and died in some documented cases. This has raised concerns about pet exposure and raw milk consumption. Pigs are a particular concern for pandemic risk because pigs can be simultaneously infected with human and avian influenza viruses, creating conditions for genetic reassortment — the mixing of viral genes that produced the 2009 H1N1 pandemic virus. Swine infections with H5N1 have been detected in some contexts, which public health officials monitor closely.

Is Raw Milk Safe? The Dairy Connection

The U.S. dairy cattle outbreak raised a specific question about raw (unpasteurized) milk. H5N1 was detected at very high concentrations in the milk of infected cows, and laboratory experiments confirmed that the virus in raw milk was capable of infecting other mammals. Pasteurization effectively inactivates influenza viruses, meaning commercially pasteurized milk presents no H5N1 risk. Raw milk does not have this protection.

Cats given raw milk from H5N1-positive cows developed fatal illness in documented instances. The risk to humans from drinking raw milk during an active dairy herd outbreak is not precisely quantified, but the biological plausibility of transmission is real. Major food safety and public health agencies uniformly recommend against raw milk consumption, a recommendation that carries more weight during an active outbreak in dairy cattle. This is consistent with the broader evidence base around the practical preventive measures that reduce infectious disease risk in everyday life.

Symptoms: What Human Infection Looks Like

Human H5N1 illness has presented across a wide spectrum in recent cases. In the U.S. dairy-associated outbreak, many cases were mild — primarily conjunctivitis (red, watery, irritated eyes), sometimes with fever and mild respiratory symptoms, resolving without hospitalization. In other settings and other exposure routes, H5N1 in humans has produced severe pneumonia, acute respiratory distress, multiorgan failure, and death. The difference in severity likely reflects viral variant, exposure dose, exposure route, underlying health status, and how quickly antiviral treatment was started.

The incubation period is typically 2–5 days but can extend to about 10 days. Because early symptoms can overlap with ordinary influenza and the common cold — fever, cough, sore throat, muscle aches — the distinguishing feature for diagnostic purposes is recent exposure to potentially infected birds or animals. Anyone with those symptoms and a known exposure history should contact a healthcare provider promptly and mention the exposure, since testing and early antiviral treatment (oseltamivir/Tamiflu) are most effective when started early.

Antivirals and Treatment

Oseltamivir (Tamiflu) and other neuraminidase inhibitors are effective against H5N1 when started early. Governments maintain strategic stockpiles of these medications for pandemic response. For exposed farm workers and others with occupational risk, antiviral prophylaxis (taking oseltamivir preventively after a known exposure) has been used and is recommended in some guidelines. The evidence for antiviral effectiveness is clearest when treatment begins within 48 hours of symptom onset, which makes early recognition and rapid access to testing and treatment important — following the same principle of matching the treatment approach to the underlying mechanism and starting it promptly.

For severe cases, intensive care support including mechanical ventilation has been required in fatalities and near-fatal cases. There is no widely available H5N1-specific antiviral beyond oseltamivir and related drugs, though antiviral research is ongoing.

Vaccines: Where Things Stand

H5N1 vaccine candidates have been in development and maintained in preparedness stockpiles for years. Several H5N1 vaccines have been approved or authorized in the U.S. and other countries, intended for use in the event of a pandemic or in high-risk populations. The challenge with influenza vaccine preparedness is that the virus changes, and a vaccine developed against one clade may provide incomplete protection against a diverged variant — a limitation familiar from seasonal flu vaccination, where annual reformulation tries to match circulating strains.

As of recent reports, manufacturers have been working to update H5N1 vaccine candidates to better match the clade 2.3.4.4b strains driving the current global wave. mRNA vaccine platforms, which can be updated relatively quickly, are among the technologies being applied to H5N1 candidates. Routine H5N1 vaccination for the general public has not been recommended by health authorities because the virus does not yet transmit between humans efficiently — the recommendation would change rapidly if that status changed.

Risk Assessment for Most People

For the general public without occupational exposure to poultry, livestock, or wild birds, the current risk from H5N1 is low. The virus has not acquired sustained human-to-human transmission capability, and there is no evidence of community spread. The risk is concentrated in people who work with or around infected animals — farm workers, veterinarians, wildlife biologists, slaughterhouse workers — and people who consume raw milk or have close contact with sick backyard poultry or wild birds.

Risk reduction for most people is straightforward: avoid handling sick or dead wild birds, wash hands after any bird or animal contact, avoid raw milk from regions with known H5N1 outbreaks, and cook poultry and eggs to safe internal temperatures (standard food safety practice that also addresses this risk). Workers with occupational exposure should use appropriate personal protective equipment — N95 respirators, eye protection, gloves, and gowns during handling of potentially infected animals — consistent with current occupational health guidance. These precautions align with the same evidence-based approach that underpins the broader principle of addressing actual risk mechanisms rather than just visible symptoms.

What Would Indicate a Pandemic Risk Escalation

Public health agencies are watching for specific signals that would indicate H5N1 is moving toward pandemic potential. The most important would be documented, sustained human-to-human transmission — cases in people without known animal exposure, or clear chains of transmission from one person to another across multiple generations. Secondary signals include detection of specific mutations in circulating strains known to enhance human respiratory cell attachment or airborne transmissibility, and rapid geographic spread in humans rather than just animals.

The WHO's influenza risk assessment for H5N1 in humans has remained at a level indicating significant concern but not imminent pandemic risk. That assessment is updated as new cases and new genomic data emerge. The machinery for escalating to pandemic response — accelerated vaccine production, antiviral deployment, international coordination through the International Health Regulations framework — exists and has been exercised. Whether it gets activated depends on how the virus evolves. This kind of evidence-based monitoring for emerging risk, rather than either dismissing or catastrophizing, is consistent with the approach recommended across health risk domains, including how evidence-based nutritional guidance weighs actual risk data against default assumptions.

Lessons from Prior Outbreaks and Pandemic History

H5N1 has been circulating and causing alarm since it was first identified in domestic geese in China in 1996 and killed a child in Hong Kong in 1997. It has persisted for nearly three decades without causing a pandemic — a fact that warrants appropriate humility about predictions in both directions. Influenza viruses are difficult to predict; the 2009 H1N1 pandemic came from swine influenza that surprised virologists with both its emergence and its relative mildness. H5N1's high fatality rate in confirmed cases has led to fears of a catastrophic pandemic if it ever develops efficient human transmission; the counterweight is that high virulence and high transmissibility are often in evolutionary tension, and a highly lethal variant may be selected against if it kills hosts too quickly to spread.

None of this is cause for complacency. The current H5N1 situation is genuinely more concerning than prior episodes because of the breadth of mammal species infected, the sustained presence in dairy cattle with their associated human exposure, and the increasing volume of human cases. But the appropriate response is sustained surveillance, preparedness investment, occupational protection for at-risk workers, and clear public communication — not panic, and not dismissal. The population-level response framework that public health agencies are building toward H5N1 follows the same logic as the evidence-based approach to any health risk: understand the mechanism, calibrate the response to actual rather than assumed risk, and intervene specifically where the evidence supports it.

What You Should Actually Do

For most people, the practical steps are modest: follow standard food safety with poultry and eggs, avoid raw milk especially during active outbreak periods, don't handle sick or dead wild birds, and stay informed through reliable public health sources (CDC, WHO, and state health departments for U.S. residents). If you work in agriculture, poultry processing, or with animals professionally, follow your employer's and public health guidance on protective equipment and exposure reporting, and know that antivirals are effective if started quickly — which means mentioning animal exposure to a doctor promptly if you develop flu-like symptoms after working with potentially infected animals.

H5N1 hasn’t become a pandemic virus yet, and it may not. But the conditions for concern are genuinely present in a way they haven’t been in most of the prior decades of H5N1 surveillance, and the appropriate posture is informed awareness — understanding what the risk actually is, what would change if it escalated, and what practical steps make sense given where things stand right now.